Effects of dextromethorphan in clinical doses on capsaicin-induced ongoing pain and mechanical hypersensitivity

Journal of Pain and Symptom Management

Volumn 14, Issue 4, 1997, Pages 195-201

  Kinnman, Erik ^a,b   Nygårds, Eva Britt ^b   Hansson, Per ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allodynia; Capsaicin; Dextromethorphan; Hyperalgesia; Inflammation; NMDA receptor; Pain; Peripheral

Indexed keywords

CAPSAICIN; DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; INTRADERMAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PAIN THRESHOLD; SKIN TEMPERATURE; STIMULUS RESPONSE;

ADULT; ANALGESICS; CAPSAICIN; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PAIN; STRESS, MECHANICAL;

EID: 0343247770     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00180-2     Document Type: Article

References (42)

1. LaMotte RH, Shain CN, Simone DA, Tsai EF. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991;66: 190-211.
2. Lewis T. Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin Sci 1935;2:373-423.
3. Cook AJ, Woolf CJ, Wall PD, McMahon SB. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987;325:151-153.
4. Hardy JD, Woolf HG, Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 1950;29:115-140.
5. Koltzenburg M, Torebjörk HE, Wahren LK. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 1994;117:579-591.
6. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep dorsal horn nociceptive neurons following C fibre stimulation. Neuropharmacology 1987;26:1235-1238.
7. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-299.
8. Davar G, Hama A, Deykin A, Vos B, Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1991;553:327-330.
9. Eisenberg E, LaCross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Lett 1995;187:17-20.
10. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ, Frenk H. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 1993;605:164-168.
11. Seltzer Z, Cohn S, Ginzburg R, Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 1991;45:69-75.
12. Smith GD, Wiseman J, Harrison SM, Elliott PJ, Birch PJ. Pre treatment with MK-801, a noncompetitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation. Neurosci Lett 1994;165:79-83.
13. Tal M, Bennett GJ. Neuropathic pain sensations are differentially sensitive to dextrorphan. Neuroreport 1994;5:1438-1440.
14. Yamamoto T, Yaksh TL. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 1992;49:121-128.
15. Yamamoto T, Yaksh TL. Comparison of the antinociceptive effects of pre-and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992;77:757-763.
16. Dougherty PM, Palecek J, Paleckova V, Sorkin LS, Willis WD. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 1992;12:3025-3041.
17. Eisenberg E, LaCross S, Strassman AM. The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats. Eur J Pharmacol 1994; 255:123-129.
18. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain 1993; 54:301-307.
19. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996;64:283-291.
20. Eide PK, Joørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994;58:347-354.
21. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994;56:51-57.
22. Kristensen JD, Svensson B, Gordh TJ. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992;51:249-253.
23. Price DD, Mao J, Frank H, Mayer DJ. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994;59:165-174.
24. Simone DA, Baumann TK, Lamotte RH. Dosedependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989;38:99-107.
25. Koltzenburg M, Lundberg LE, Torebjörk HE. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992;51: 207-219.
26. Torebj̈rk HE, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol (Lond) 1992;448:765-780.
27. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine and alfentanil on hyperalgesia induced by intradermal capsaicin. In: Gebhart GF, Hammond DL, Jensen TS, eds. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press, 1994:647-655.
28. Jensen K, Andersen HO, Olesen J, Lindblom U. Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain 1986; 25:313-323.
29. Franklin PH, Murray TF. High affinity [3H] dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol Pharmacol 1992;41:134-146.
30. Netzer R, Pflimlin P, Trube G. Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur J Pharmacol 1993;238:209-216.
31. Church J, Sawyer D, McLarnon JG. Interactions of dextromethorphan with the N-methyl-Daspartate receptor-channel complex: single channel recordings. Brain Res 1994;666:189-194.
32. Cole AE, Eccles CU, Aryanpur JJ, Fisher RS. Selective depression of N-methyl-D-aspartatemediated responses by dextrorphan in the hippocampal slice in rat. Neuropharmacology 1989;28: 249-254.
33. Wong BY, Coulter DA, Choi DW, Prince DA. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices. Neurosci Lett 1988;85:261-266.
34. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo MJ. Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 1988; 151: 151-154.
35. Choi DW, Peters S, Viseskul V. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 1987;242:713-720.
36. Steinberg GK, Saleh J, Kunis D. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia. Neurosci Lett 1988;89:193-197.
37. Lee SH, Kayser V, Desmeules J, Guilbaud G. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats. Pain 1994;57:233-240.
38. Konietzny F, Hensel H. The effect of capsaicin on the response characteristics of human C-polymodal nociceptors. J Therm Biol 1983;8:213-215.
39. LaMotte RH, Lundberg LE, Torebjörk HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol (Lond) 1992;448:749-764.
40. Sato K, Kiyama H, Park HT, Tohyama M. AMPA, KA and NMDA receptors are expressed in the rat DRG neurones. Neuroreport 1993;4:1263-1265.
41. Furuyama T, Kiyama H, Sato K, et al. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. Mol Brain Res 1993; 18: 141-151.
42. Tolle TR, Berthele A, Zieglgansberger W, Seeburg PH, Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 1993; 13:5009-5028.